ArticleBlood advances2019

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.

Hanne Due et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.